federal_register: 2019-06438

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
2019-06438 The Future of Insulin Biosimilars: Increasing Access and Facilitating the Efficient Development of Biosimilar and Interchangeable Insulin Products; Public Hearing; Request for Comments Proposed Rule The Food and Drug Administration (FDA or the Agency) is announcing a public hearing to discuss access to affordable insulin products and issues related to the development and approval of biosimilar and interchangeable insulin products. 2019-04-03 2019 4 https://www.federalregister.gov/documents/2019/04/03/2019-06438/the-future-of-insulin-biosimilars-increasing-access-and-facilitating-the-efficient-development-of https://www.govinfo.gov/content/pkg/FR-2019-04-03/pdf/2019-06438.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA or the Agency) is announcing a public hearing to discuss access to affordable insulin products and issues related to the development and approval of biosimilar and interchangeable insulin products.

Links from other tables